Pemigatinib is an oral targeted drug for the treatment of FGFR2 fusion‑positive advanced cholangiocarcinoma.
Authentic
Guarantee
Fast Delivery
Privacy Pemigatinib is a kinase inhibitor used to treat previously treated adult patients with unresectable locally advanced or metastatic cholangiocarcinoma ···【Read More】
Update: 10 Mar,2026Source: Haiou HealthViews: 72
Copyright2024@ BIGBEAR All right reserved BIGBEAR



